Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire

Recruiting Observational Study
Diabetic Neuropathies Diabetic Peripheral Neuropathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Observational
Participants needed
290 (estimated)
Sponsor
Cairo University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
PURPOSE: This study will translate, culturally adapt, validate, and test the reliability of the Neuro Qol Arabic version to be used with diabetic patients in Arabic countries. Background: The Neuropathy- and Foot Ulcer-Specific Quality of Life instrument is a multidimensional scale was developed to assess the QoL of diabetic patients with peripheral neuropathy. Producing Arabic versions of the Tr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Arabic is their first language The absence of any other neurological diagnosis affecting the sensory and motor system, such as stroke or multiple sclerosis * Age ranges between 18 and 70 years, * History of DM diagnosed by a physician and confirmed by either hemoglobin A1c ≥6.…
Contacts

Engy BadrEldin S Moustafa, PhD

00201099445112

engybm.saleh@cu.edu.eg

CONTACT

Shimaa T. AbulKasem, PhD

00201229823327

dr.shymaelshazly@yahoo.com

CONTACT